Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer (original) (raw)

Adjuvant aromatase inhibitors for breast cancer

Anthony Howell

The Lancet, 2005

View PDFchevron_right

Residual Risk of Breast Cancer Recurrence 5 Years After Adjuvant Therapy

Francisco Esteva

JNCI: Journal of the National Cancer Institute, 2008

View PDFchevron_right

Treatment strategies that effectively reduce early recurrence risk in postmenopausal women with endocrine-sensitive breast cancer: AIs upfront vs. switching

M. Warm, Anke Thomas, Sherko Kümmel

Journal of Cancer Research and Clinical Oncology, 2007

View PDFchevron_right

Minimizing early relapse and maximizing treatment outcomes in hormone-sensitive postmenopausal breast cancer: efficacy review of AI trials

Antonio Atenas

Cancer and Metastasis Reviews, 2010

View PDFchevron_right

Adjuvant and extended adjuvant use of aromatase inhibitors: Reducing the risk of recurrence and distant metastasis

Joseph Gligorov

The Breast, 2007

View PDFchevron_right

Current treatment of early breast cancer: adjuvant and neoadjuvant therapy

BORA LIM

F1000Research, 2014

View PDFchevron_right

Development of a Prognostic Tool to Guide the Decision to Extend Adjuvant Aromatase Inhibitors for up to Ten Years in Postmenopausal Early Breast Cancer Patients

Camille Moreau-Bachelard

Cancers

View PDFchevron_right

Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05)

A. van Leeuwen-Stok

JNCI: Journal of the National Cancer Institute, 2017

View PDFchevron_right

Aromatase inhibitors in the management of early breast cancer

jean-marc nabholtz

Ejso, 2008

View PDFchevron_right

Defining the roles of aromatase inhibitors in the adjuvant treatment of early-stage breast cancer

Anthony Howell, Gershon Locker

Clinical breast cancer, 2005

View PDFchevron_right

Update on adjuvant hormonal treatment of early breast cancer

Salvador Juan

Advances in Therapy, 2011

View PDFchevron_right

Prevention of breast cancer recurrence with adjuvant cytotoxic or endocrine therapy

Lars Rutqvist

Medical oncology and tumor pharmacotherapy, 1991

View PDFchevron_right

Aromatase Inhibitors for the adjuvant treatment of breast cancer in postmenopausal women

Joseph Beyene

View PDFchevron_right

Adjuvant Therapy for Early Breast Cancer

Muaiad Kittaneh

New England Journal of Medicine, 2007

View PDFchevron_right

An updated review on the efficacy of adjuvant endocrine therapies in hormone receptor–positive early breast cancer

Shail Verma

Current Oncology, 2009

View PDFchevron_right

Practical consensus recommendations on duration of adjuvant hormonal therapy in breast cancer

purvish parikh

South Asian journal of cancer

View PDFchevron_right

Adjuvant endocrine therapy for postmenopausal breast cancer in the era of aromatase inhibitors: an update

Isabella Karat

International seminars in surgical oncology : ISSO, 2006

View PDFchevron_right

Aromatase inhibitors as adjuvant treatment of breast cancer

Per Lønning

Critical Reviews in Oncology/Hematology, 2006

View PDFchevron_right

From adjuvant to preventive breast cancer treatment: bridging the gap over troubled waters

Corrado Ficorella

Annals of Oncology, 2006

View PDFchevron_right

Extended Adjuvant Endocrine Therapy in Breast Cancer: Current Status and Future Directions

Marcel Jinih

Clinical Cancer Updates, 2008

View PDFchevron_right

Evolution of endocrine adjuvant therapy for early breast cancer

Per Lønning

Expert Opinion on Investigational Drugs, 2010

View PDFchevron_right

Controversial Issues in Adjuvant Systemic Therapy of Early Breast Cancer

Lars Rutqvist

Acta Oncologica, 1998

View PDFchevron_right

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

Simon Spazzapan

The New England journal of medicine, 2018

View PDFchevron_right

Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: A systematic review

K. Pritchard

Cancer Treatment Reviews, 2008

View PDFchevron_right

Initial treatment and changes in adjuvant endocrine therapy for early stage breast cancer

Arthur Houts

The Breast, 2009

View PDFchevron_right

Concurrent vs Sequential Adjuvant Chemotherapy and Hormone Therapy in Breast Cancer: A Multicenter Randomized Phase III Trial

P. Taveggia

JNCI Journal of the National Cancer Institute, 2011

View PDFchevron_right

Enhancing the Adjuvant Treatment of Hormone Receptor Positive Breast Cancer

Mitchel Barry

The Breast Journal, 2009

View PDFchevron_right

Adjuvant therapy in breast cancer

Rochelle Strenger

Obstetrics and Gynecology Clinics of North America, 2002

View PDFchevron_right

Role of aromatase inhibitors in the upfront adjuvant hormonal therapy of postmenopausal patients with breast cancer

Jean-Marc Nabholtz

Indian Journal of Surgical Oncology, 2010

View PDFchevron_right

Optimal adjuvant endocrine therapy for early breast cancer

Robin Stuart-harris

Women's Health, 2010

View PDFchevron_right

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years

Judith Kaur

New England Journal of Medicine, 2016

View PDFchevron_right

Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma

Francesco Boccardo

Cancer, 2007

View PDFchevron_right

Adjuvant Hormone Therapy for Breast Cancer

bruna zucchetti

Breast Diseases, 2019

View PDFchevron_right